Pharming Group (XAMS:PHARM) Shares Buyback Ratio %: -0.91 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XAMS:PHARM Pharming Group XAMS:PHARM
70 GF Score
Price €0.92
GF Value €1.08
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Pharming Group Shares Buyback Ratio %?

Pharming Group XAMS:PHARM -2.28% 70 Shares Buyback Ratio % is -0.91 as of Sep. 21, 2026. GuruFocus rates XAMS:PHARM with a GF Score™ of 70/100 and a GF Value™ of €1.08 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Pharming Group's current shares buyback ratio was -0.91%.

Pharming Group Shares Buyback Ratio % Related Terms

Pharming Group Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Pharming Group's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharming Group Shares Buyback Ratio % Chart

Pharming Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.55 -1.17 -2.24 -1.38 -3.14

Pharming Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.71 0.00 -2.41 0.04 -0.91
XAMS:PHARM
70GF Score
Pharming Group XAMS:PHARM
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharming Group Shares Buyback Ratio % Calculation

Pharming Group's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(680.308735 - 701.68044) / 680.308735
=-3.14%

Pharming Group's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(701.404 - 707.78124) / 701.404
=-0.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -0.91 mean?
Pharming Group (XAMS:PHARM) has a Shares Buyback Ratio % of -0.91 as of Sep. 21, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Pharming Group and its competitors.
Is Pharming Group's Shares Buyback Ratio % too high?
Pharming Group's current Shares Buyback Ratio % is -0.91. Overall, Pharming Group has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharming Group's Shares Buyback Ratio % compare to VRTX and REGN?
Pharming Group's Shares Buyback Ratio % of -0.91 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Pharming Group and its competitors. Pharming Group's current Shares Buyback Ratio % is -0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharming Group stock overvalued right now?
Based on GuruFocus' analysis, Pharming Group (XAMS:PHARM) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.08, compared to a current price of €0.92 — trading 15.1% below its estimated fair value. The current Shares Buyback Ratio % is -0.91. Pharming Group's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Pharming Group (XAMS:PHARM), the current Shares Buyback Ratio % is -0.91 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharming Group (XAMS:PHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Pharming Group stock appears to be undervalued. The current stock price of €0.92 is trading 15.1% below its estimated GF Value™ of €1.08. GuruFocus considers Pharming Group to be Modestly Undervalued.

Key valuation signals for XAMS:PHARM:

  • Shares Buyback Ratio %: -0.91
  • GF Value™: €1.08 vs. price of €0.92 (15.1% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the XAMS:PHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharming Group Business Description

Address Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
70GF Score

Get the complete analysis for XAMS:PHARM

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.92
Price
€1.08
GF Value